Summarized by Masters of Longevity from Nature - Main.
An implantable NeuroAxis used glucose power to normalize glycaemia in diabetic rats.

Key Takeaways
- The device is powered solely by endogenous glucose in rats.
- Closed-loop neuromodulation restored glucose tolerance and insulin sensitivity.
- Evidence was in rat models and is not proof in humans.



